Literature DB >> 1967977

Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses.

J Couturier1, O Delattre, M Kujas, J Philippon, M Peter, G Rouleau, A Aurias, G Thomas.   

Abstract

We report the cytogenetic study of 28 neurinomas; sixteen of them were also analysed using 11 polymorphic DNA markers for the loss of alleles of chromosome 22. Partial or total loss of chromosome 22 was found in nine cases. The results of the two approaches appear homogeneous, however, three tumors that yielded only cells with normal karyotypes demonstrated loss of constitutional heterozygosities. One of the tumors, which displayed an isodicentric or isopseudodicentric 22, was obtained in a patient with von Recklinghausen neurofibromatosis. It appears that loss of chromosome 22 is a characteristic of neurinomas whatever their context of occurrence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967977     DOI: 10.1016/0165-4608(90)90066-j

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Ancient neurilemmoma of the pelvis.

Authors:  T W Hennigan; A C Branfoot; N A Theodorou
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

2.  The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

Authors:  Erika Celis-Aguilar; Luis Lassaletta; Miguel Torres-Martín; F Yuri Rodrigues; Manuel Nistal; Javier S Castresana; Javier Gavilan; Juan A Rey
Journal:  Genet Res Int       Date:  2012-02-20

3.  Leiomyosarcoma of the Oropharynx and Neurogenic Tumors in a Young Patient With Turner's Syndrome.

Authors:  A De Chiara; G Apice; G Silvestro; S Losito; G Botti; F Ionna; V De Rosa; A Borghese; V Ninfo
Journal:  Sarcoma       Date:  2001

4.  Giant invasive sacral schwannoma showing chromosomal numerical aberrations [-14,+18,+22].

Authors:  Masahiko Kanamori; Taketoshi Yasuda; Takeshi Hori; Kayo Suzuki
Journal:  Asian Spine J       Date:  2013-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.